Trial Information

Summary: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Tolerability, Titration Study, to Evaluate the Efficacy and Safety of Perampanel (E2007) in Patients with Post-Herpetic Neuralgia (PHN)

Do you have pain following shingles?

You may qualify for a research study to evaluate an investigational drug
for treating post-herpetic neuralgia.

Study Details:

- 8 or 11 outpatient visits at Brigham and Women’s Hospital in Boston.
- Study will last 21 weeks.
- All study-related costs at no charge.
- Compensation will be provided.

Please contact Kerry or Jess at 617-525-PAIN (617-525- 7246) or PainTrials@partners.org.

Contact:

Jessica Schillinger, BA
Brigham and Women's Hospital (BWH)
75 Francis Street
Boston, MA 02115
Telephone: 617-525-7246
Email:

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: July 7, 2008 at 3:20:44 PM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA